Farnesyl-diphosphate farnesyltransferase Information & Farnesyl-diphosphate farnesyltransferase Links at HealthHaven.com
advertise
add site
services
publishers
database
health videos
Bookmark and Share

search wiki for    ?
web dir firms image gallery news pdf wiki shop video 
about
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
Featured Results:
Nitric Oxide Synthase Inhibitors for the Treatment of Chronic...
Nitric Oxide Synthase Inhibitors for the Treatment of Chronic...
headachedrugs.com
 Nitric Oxide Synthase s (NOS) - R&D Systems
Nitric Oxide Synthases (NOS) - R&D Systems
rndsystems.com
 by Life Extension Lip Plumper with Squalene ...
by Life Extension Lip Plumper with Squalene...
lifeextensionvitamins.com
 HealthWalk - Supplements - Squalene
HealthWalk - Supplements - Squalene
healthwalk.com
 
farnesyl-diphosphate farnesyltransferase 1
Identifiers
Symbol FDFT1
Entrez 2222
HUGO 3629
OMIM 184420
RefSeq NM_004462
UniProt P37268
Other data
EC number 2.5.1.21
Locus Chr. 8 p23.1-p22

Farnesyl-diphosphate farnesyltransferase (FDFT1) (or squalene synthase (SQS)) is an enzyme that converts two units of farnesyl pyrophosphate into squalene.

Reaction

It has been described as the first dedicated enzyme of sterol (i.e., cholesterol, etc.) synthesis, since the squalene formed by it is exclusively routed into various sterols via a complex, multi-step pathway.

Contents

[edit] Diversity

Squalene synthase is considered to be an enzyme of eukaryotes or advanced organisms, although at least one prokaryote has been shown to possess a functionally similar enzyme.

In terms of structure and mechanics, squalene synthase most closely resembles phytoene syntase, which serves a similar role in many plants in the elaboration of phytoene, a precursor of many carotenoid compounds. (Carotenoids are the colorful pigments present in most vegetables.)

[edit] Clinical significance

Inhibition of squalene synthase, e.g., by lapaquistat, is under investigation as a method of lowering cholesterol levels in the prevention of cardiovascular disease.[1][2] It has also been suggested that variants in this enzyme may be part of a genetic association with hypercholesterolemia.[3]

Squalene synthase homolog inhibition in Staphylococcus aureus is currently being investigated as a virulence factor-based antibacterial therapy. [4]

[edit] References

  1. ^ Davidson, MH (January 2007). "Squalene synthase inhibition: a novel target for the management of dyslipidemia". Curr Atheroscler Rep 9 (1): 78–80. doi:10.1007/BF02693932. PMID 17169251. 
  2. ^ Charlton-Menys V, Durrington PN (2007). "Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential". Drugs 67 (1): 11–6. PMID 17209661. 
  3. ^ Do R, Kiss RS, Gaudet D, Engert JC (January 2009). "Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway". Clin. Genet. 75 (1): 19–29. doi:10.1111/j.1399-0004.2008.01099.x. PMID 19054015. http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0009-9163&date=2009&volume=75&issue=1&spage=19. 
  4. ^ Liu et al. (2008). "A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence". Science 319: 1391. doi:10.1126/science.1153018. PMID 18276850. 

[edit] External links





Product Results (view all...)

search wiki for    ?
web dir firms image gallery news pdf wiki shop video 



↑ top of page ↑about thumbshots